Chemicals & Advanced Materials Global On demand · 24-48h

Global 1,4-Cyclohexanediol Market Strategic Research Report

Global 1,4-Cyclohexanediol Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global 1,4-Cyclohexanediol Market
$2112025
5.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Purity ≥ 99.5%, Purity < 99.5%

By Application: Chemical Industry, Pharmaceutical Industry

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Jiangsu Congzhong Chemical, Hubei BaiDu Chemical, Shanghai Licas Industry, Hubei Qianmomo Technology, Weifang Eddie Chemical, Shanghai Tongyuan Chemical, Wuhan Kemik Biomedicine, Shanghai Biyang Industry, Lianyungang Chunda Chemical Technology, Hubei Yongkuo Technology, Hubei Shishun Biotechnology, Hubei Yunmei Technology, Somu Group, Jiangsu Bosite Chemical, Hubei Shineng Chemical Technology, Tianmen Hengchang Chemical, Hubei Jiufenglong Chemical, Wuhan Xinxin Jiali Biotechnology, Hubei Xinmingtai Chemical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 145 pages
Market size 2025
$211
Million USD
Forecast CAGR
5.4%
2025-2032
Forecast 2032
$304.9
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global 1,4-Cyclohexanediol market size is predicted to grow from US$ 211 million in 2025 to US$ 304 million in 2032; it is expected to grow at a CAGR of 5.4% from 2026 to 2032.

1,4-Cyclohexanediol is a cyclic diol compound containing two hydroxyl groups, with the chemical formula C6H12O2. It is a dihydroxy derivative of cyclohexane, with the hydroxyl groups located on carbon atoms 1 and 4, and has two isomers, cis and trans. The presence of dihydroxy groups makes it highly reactive and can participate in a variety of chemical reactions, such as esterification, oxidation, and condensation. It appears as a white solid or powdery crystal. The melting point is about 110–115°C (depending on the isomer). It is soluble in water, alcohols, and other polar solvents.

Compared with 1,4-cyclohexanedimethanol, although the two have similar names, in terms of use, 1,4-cyclohexanedimethanol is more commonly used in engineering plastics and coating resins, while 1,4-cyclohexanediol is more commonly used in medicine and high-performance materials.

With the continuous development of the global economy, the demand for 1,4-cyclohexanediol in downstream industries such as polyester materials, coating materials, and liquid crystal materials continues to increase. For example, in the field of polyester materials, 1,4-cyclohexanediol can be used to produce high-performance polyester fibers, engineering plastics, etc. As people pursue high-quality life, the demand for these high-performance materials is also rising, which has brought a broad market space for the 1,4-cyclohexanediol industry.

The continuous development of new production processes and catalysts helps to improve the production efficiency, reduce production costs and improve product quality of 1,4-cyclohexanediol. This not only enhances the competitiveness of enterprises, but also makes the application range of 1,4-cyclohexanediol wider and further expands the market. For example, by optimizing reaction conditions and improving catalysts, the production process can be made more efficient and environmentally friendly, while improving the purity and stability of the product.

In the context of increasingly stringent environmental protection policies, 1,4-cyclohexanediol, as a relatively environmentally friendly chemical raw material, is expected to increase its market demand. Compared with some traditional chemical products, 1,4-cyclohexanediol produces fewer pollutants during production and use, which meets the requirements of sustainable development. For example, in industries such as coatings and plastics, the use of 1,4-cyclohexanediol can reduce the emission of volatile organic compounds (VOCs), helping companies meet the requirements of environmental regulations.

The relevant industrial policies issued by the government, such as support policies for high-performance materials, new energy vehicles and other fields, have indirectly promoted the development of the 1,4-cyclohexanediol industry. These policies encourage companies to increase R&D investment, improve product quality and technical level, and promote the application of 1,4-cyclohexanediol in related fields.

This report presents a comprehensive overview of the global 1,4-Cyclohexanediol market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Purity ≥ 99.5%
  • Purity < 99.5%

Segment by Application

  • Chemical Industry
  • Pharmaceutical Industry

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global 1,4-Cyclohexanediol market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Chemical Industry, Pharmaceutical Industry evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global 1,4-Cyclohexanediol Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$211
2025
Forecast
$304.9
2032
CAGR
5.4%
2025–2032
Régions
5
global
Key companies
Jiangsu Congzhong ChemicalHubei BaiDu ChemicalShanghai Licas IndustryHubei Qianmomo TechnologyWeifang Eddie ChemicalShanghai Tongyuan ChemicalWuhan Kemik BiomedicineShanghai Biyang Industry
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Purity ≥ 99.5%Purity < 99.5%
By Application
Chemical IndustryPharmaceutical Industry

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Purity ≥ 99.5%
  • 3.1.3 Purity < 99.5%
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Chemical Industry
  • 4.1.3 Pharmaceutical Industry
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Jiangsu Congzhong Chemical
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Hubei BaiDu Chemical
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Shanghai Licas Industry
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Hubei Qianmomo Technology
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Weifang Eddie Chemical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Shanghai Tongyuan Chemical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Wuhan Kemik Biomedicine
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Shanghai Biyang Industry
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Lianyungang Chunda Chemical Technology
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Hubei Yongkuo Technology
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Hubei Shishun Biotechnology
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Hubei Yunmei Technology
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Somu Group
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Jiangsu Bosite Chemical
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Hubei Shineng Chemical Technology
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Tianmen Hengchang Chemical
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Hubei Jiufenglong Chemical
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Wuhan Xinxin Jiali Biotechnology
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Hubei Xinmingtai Chemical
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global 1,4-Cyclohexanediol market?
The global 1,4-Cyclohexanediol market is estimated at US$ 211 million in 2025 (base year) and is projected to reach US$ 304 million by 2032.
What is the forecast CAGR for the 1,4-Cyclohexanediol market?
The market is expected to grow at a CAGR of 5.4% from 2026 to 2032, expanding from US$ 211 million in 2025 to US$ 304 million in 2032, roughly 1.4 times its base-year value.
What is 1,4-Cyclohexanediol?
1,4-Cyclohexanediol is a cyclic diol compound containing two hydroxyl groups, with the chemical formula C6H12O2. It is a dihydroxy derivative of cyclohexane, with the hydroxyl groups located on carbon atoms 1 and 4, and has two isomers, cis and trans. The presence of dihydroxy groups makes it highly reactive and can participate in a variety of chemical reactions, such as esterification, oxidation, and condensation.
What are the main segments of the 1,4-Cyclohexanediol market by type?
By type, the market is segmented into Purity ≥ 99.5% and Purity < 99.5%.
Which applications drive demand in the 1,4-Cyclohexanediol market?
Key applications covered include Chemical Industry and Pharmaceutical Industry.
Who are the key players in the 1,4-Cyclohexanediol market?
Key players profiled include Jiangsu Congzhong Chemical, Hubei BaiDu Chemical, Shanghai Licas Industry, Hubei Qianmomo Technology, Weifang Eddie Chemical, Shanghai Tongyuan Chemical, Wuhan Kemik Biomedicine and Shanghai Biyang Industry, among 19 companies covered in total.
Which regions and countries are covered for 1,4-Cyclohexanediol?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What challenges does the 1,4-Cyclohexanediol market face?
For example, in industries such as coatings and plastics, the use of 1,4-cyclohexanediol can reduce the emission of volatile organic compounds (VOCs), helping companies meet the requirements of environmental regulations.
Who should buy the 1,4-Cyclohexanediol market report?
The report is intended for manufacturers and solution providers, distributors and end users in Chemical Industry and Pharmaceutical Industry, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the 1,4-Cyclohexanediol market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.